Canary Capital Moves Towards Injective Staking ETF – A Step Towards Mainstream Access

Digital asset investment firm Canary Capital has taken a significant step towards bringing the altcoin Injective (INJ) into mainstream financial markets. The company has registered an entity in Delaware to stand behind its proposed Injective (INJ) exchange-traded fund (ETF). This registration is a pivotal move as it marks an early, crucial stage in a potential long and complex process that ultimately requires approval from regulatory bodies such as the U.S. Securities and Exchange Commission (SEC). This development signals growing institutional interest in bringing more crypto assets into regulated investment products.